国家医保局正式印发《检验类医疗服务价格项目立项指南(试行)》，为全国检验类医疗服务价格建立统一规范[1]。该指南设置662个主项目、114个加收项和7个扩展项[1]，并将130余项新项目纳入全国统一收费目录[1]。
指南通过"同检同价"原则，规定同一检验指标原则上不再因检测方法学差异而设立不同主项目[1]，实现同一检验指标按服务产出统一定价。联检折扣政策同步实施，即联检指标不超过5个时按80%计价，不超过10个时按70%计价，超过10个时按60%计价[1]。这些措施旨在降低患者负担，并推进检验结果的全国互认[1]。
本次指南发布标志着历时多年的40批医疗服务价格项目立项指南编制工作圆满收官[1]。
The National Medical Insurance Bureau has formally issued the Guidelines for Laboratory Testing Medical Service Price Project Application (Provisional), establishing uniform standards for laboratory testing price projects across the country [1]. The guidelines represent the conclusion of a multi-year effort spanning 40 batches of medical service price project application guidance development [1].
The framework establishes 662 primary projects, 114 surcharge items, and 7 extension items [1]. Under the new system, the same laboratory testing indicator is no longer differentiated by testing methodology at the primary project level, achieving unified pricing for identical tests [1]. Additionally, 130 or more new items have been incorporated into the national unified fee directory [1].
To reduce patient burden and promote mutual recognition of test results nationwide, the guidelines implement a bundled testing discount structure and a "deduction for missing data" policy [1]. Under the bundled testing discount system, when five or fewer tests are ordered together, they are reimbursed at 80 percent of the standard rate; when six to ten tests are combined, the rate is 70 percent; and when more than ten tests are performed together, the rate is 60 percent [1].